What’s new in biomarker testing for ovarian cancer
April 10, 2019
Three tests are now FDA-approved for triaging pelvic masses in asymptomatic women.
Andrew John Li, MD
Letters to the Editor
July 1, 2012
Letters discuss the myriad of issues affecting the practice of specialties. Joshua A. Copel responds.
Letters to the Editor
June 1, 2012
Letters discuss global endometrial ablations, intrauterine scarring, and disagreements over cancer biomarkers. Steven R. Goldstein and Andrew John Li respond.
